FBDD Fragments Base Drugs Discovery | Design
Login |
 Shopping Cart
 
Items : (0) Total: $ 0.00

               
Search    
21-Dec-2007
  IOTA announces FBDD screening services
   
21-Dec-2007
  IOTA announces collaboration with Vitas M-laboratory and new FBDD library:IOTA-Vitas 4000
   
25-Sep-2007
  IOTA Pharmaceuticals established; research centers in the UK, the Netherlands, and India.
   
25-Sep-2007
  IOTA announces FBDD Initiative with the VU University, Amsterdam
   
25-Sep-2007
  IOTA announces first FBDD product: IOTA Diverse 1500
   
 
 
In addition to IOTA’s own in-house organic chemistry and drug discovery capabilities in Amsterdam, we have strong links with the emerging chemistry company, Oxygen Healthcare.
 
IOTA’s co-founders include Sunil and Prashant Shah, directors of Oxygen Healthcare Ltd. O2H has built its company around utilising chemistry skills and resources from both the UK and India. The company has computational chemistry, project management and logistical supplies support in Cambridge, UK, while its wet labs are based in Ahmedabad, India. O2H was formed in 2003 and has now grown to 50 scientists. It has undertaken successful projects for both large and small biopharmaceutical companies in the EU, USA and Japan.
 
 
IOTA Chemistry
On-line LibrariesFragment Chemistry Services
 
Copyright © 2007 IOTA Pharmaceuticals